Absolutely fair. The vendors have gotten much much better tech "in the room" as it were - CT's are lightning fast anymore, US is clearer and can do more on-the-fly analysis than ever before (e.g. highlighting bloodflow dynamically and capturing tons of data in microseconds), etc. Every modality has grown tremendously so my comment wasn't nearly fair enough in acknowledging that.

Downstream is getting better with items such as AI advancements and more sophisticated mechanisms to transfer data between systems both on-prem and cloud-based, however utilization of all of this tend to be stifled a ton by the standard issue of tech moving faster than policy. My frustration/disgruntlement is due to this issue more than anything.

Thanks for the insight and the reminder that my bubble of experience isn't the world - seriously.